Financial Ratios

PHAARMASIA LTD.

NSE : NABSE : 523620ISIN CODE : INE486I01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE43.973.99 (+9.98 %)
PREV CLOSE ( ) 39.98
OPEN PRICE ( ) 43.97
BID PRICE (QTY) 43.97 (16055)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35566
TODAY'S LOW / HIGH ( )42.99 43.97
52 WK LOW / HIGH ( ) 21.9746.2
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.84-2.270.460.791.14
   CEPS(Rs)-1.32-1.840.961.371.82
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.6211.4513.7913.4312.56
   Tax Rate(%)12.070.9634.8343.816.45
Margin Ratios
   Core EBITDA Margin(%)-5.62-10.08-0.313.352.83
   EBIT Margin(%)-5.05-9.052.464.083.38
   Pre Tax Margin(%)-5.21-9.072.413.933.24
   PAT Margin (%)-4.58-8.991.572.213.03
   Cash Profit Margin (%)-3.27-7.293.283.844.83
Performance Ratios
   ROA(%)-5.08-7.181.121.612.82
   ROE(%)-17.50-17.963.366.089.51
   ROCE(%)-19.24-18.005.2411.0710.35
   Asset Turnover(x)1.110.800.720.730.93
   Sales/Fixed Asset(x)1.801.141.321.621.70
   Working Capital/Sales(x)-12.27-29.8627.7448.39-39.60
Efficiency Ratios
   Fixed Capital/Sales(x)0.550.880.760.620.59
   Receivable days71.0579.06152.14179.73110.68
   Inventory Days70.3672.9279.9989.9351.60
   Payable days302.64255.86372.35531.25413.80
Valuation Parameters
   PER(x)0.000.0054.3817.5814.80
   PCE(x)-17.77-16.8425.9710.119.28
   Price/Book(x)2.432.701.801.041.34
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.561.220.840.390.48
   EV/Core EBITDA(x)-14.88-16.5520.006.758.65
   EV/EBIT(x)-11.02-13.4433.929.4413.25
   EV/CE(x)0.540.990.760.280.35
   M Cap / Sales0.581.230.850.390.48
Growth Ratio
   Net Sales Growth(%)59.68-13.47-18.641.0619.91
   Core EBITDA Growth(%)18.80-252.16-40.455.0311.98
   EBIT Growth(%)10.94-417.68-50.8414.9320.27
   PAT Growth(%)18.61-595.92-42.20-30.5735.73
   EPS Growth(%)18.62-595.92-42.20-30.5735.73
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.010.010.02
   Current Ratio(x)0.870.941.091.030.97
   Quick Ratio(x)0.500.460.760.710.67
   Interest Cover(x)-31.18-362.3041.9827.0723.55
   Total Debt/Mcap(x)0.000.000.000.010.02

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.